Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Centenial Surgical Suture Ltd (Scrip Code: 531380) has submitted to BSE copies of newspaper advertisements publishing its standalone unaudited financial results for Q2 and H1 FY26 ended September 30, 2025, carried in all editions of 'New Hub' and in the Mumbai edition of 'Pratahkal' on November 15, 2025. For Q2 FY26, total revenue from operations stood at Rs 1,350.41 lakhs, compared to Rs 1,433.72 lakhs in Q2 FY25. The company swung to a marginal loss before and after tax of Rs (1.20) lakhs, versus a profit of Rs 16.91 lakhs (PBT) and Rs 12.66 lakhs (PAT) in the year-ago quarter. Basic EPS was Rs (0.03) versus Rs 0.35 earlier. FY25 (year ended 31.03.2025) had reported revenue of Rs 5,363.63 lakhs with a loss of Rs (146.37) lakhs; paid-up equity capital stands at Rs 364.83 lakhs (face value Rs 10).
A marginal Q2 loss and a soft ~6% YoY revenue dip continue the weak trajectory seen in FY25's full-year loss; not a material surprise for shareholders given the small absolute scale, but it confirms the small-cap sutures maker is yet to return to consistent profitability.